Laboratory or animals. This label summarises the type of data; it is neither a recommendation to use nor a safety rating.
How we read studies and personal accounts ↗Identity
Cannabigerovarin is CBG’s propyl homologue, with a shorter side chain. A 2021 analytical study identified it alongside other impurities in hemp-derived CBG.
Terms associated with this entry: cannabigerovarin, cannabigerovarina.
Identification is not proof of usefulness
The 2021 analysis helps distinguish closely related substances. The word impurity describes their relationship to the analysed material; it does not automatically mean toxicity or benefit. Nor does it turn a commercial CBG sample into a clinically studied CBGV product.
Human cells outside a person
In 2016, CBGV was studied in cultured human sebocytes. It increased basal lipid production in that system. This does not establish treatment of dry skin, acne or another disease: a culture studies one function, but does not reproduce the whole skin or its clinical response.
What has been studied
Cellular activity generating hypotheses; no confirmed clinical benefit was identified in the reviewed sources.
Risks and gaps
The cell study does not define human safety, interactions or effects of prolonged CBGV use.
Documented forms
| Analytically identified compound | Detection in a sample is not used to recommend a commercial format. |
|---|
A molecule and a product are different things. Read about flowers, resins, oils, creams, capsules and vaping.
Experiences
We have not included a verifiable individual account in this review. We do not fill that gap with commercial stories or invented experiences.
Conclusion
For CBGV, precision means preserving the blank space. Chemical identity and cellular activity are real knowledge; they do not yet answer what would happen in a person.
Legal context
Read the Spain note and official sources. Absence from a cited list does not establish that a product is lawful.
Sources
- HPLC-UV-HRMS analysis of cannabigerovarin and cannabigerobutol, 2021 · Original research
- Differential effectiveness of selected phytocannabinoids on human sebocyte functions, 2016 · Laboratory study
Source review: 2026-11-02. No external clinical review. Corrections: info@milnubes.com.